Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Capital Expenditures: 2017-2024

Historic Capital Expenditures for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $1.2 million.

  • Bicycle Therapeutics' Capital Expenditures rose 54.94% to $674,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 133.55%. This contributed to the annual value of $1.2 million for FY2024, which is 57.84% down from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Capital Expenditures is $1.2 million, which was down 57.84% from $2.9 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Capital Expenditures registered a high of $19.0 million during FY2022, and its lowest value of $1.2 million during FY2020.
  • Over the past 3 years, Bicycle Therapeutics' median Capital Expenditures value was $2.9 million (recorded in 2023), while the average stood at $7.7 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Capital Expenditures skyrocketed by 835.32% in 2022 and then plummeted by 84.57% in 2023.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Capital Expenditures stood at $1.2 million in 2020, then spiked by 69.17% to $2.0 million in 2021, then surged by 835.32% to $19.0 million in 2022, then slumped by 84.57% to $2.9 million in 2023, then plummeted by 57.84% to $1.2 million in 2024.